Skip to content

Datenblatt ansehen

open_in_new
  1. Alles ansehen
  2. ELISA Kits & Reagents

KOA0854

Mouse CD5L ELISA Kit

Eine Lieferung in diese Region ist nicht möglich.

SKU:
KOA0854
Zusätzliche Namen:
AAC-11, AIM, API6, APOPTOSIS INHIBITOR 6, APOPTOSIS INHIBITOR OF MACROPHAGES, CD5 antigen like (scavenger receptor cysteine rich family), CD5 antigen-like, Cd5l, CD5L_HUMAN, CT 2, CT-2, Highly similar to ANTIGEN WC1.1 [Bos taurus], IgM associated peptide, IgM-associated peptide, Pdp, PRO229, SCAVENGER RECEPTOR CYSTEINE-RICH FAMILY, SP ALPHA, SP-alpha, Spalpha|CD5L
Anwendung:
ELISA
Lagerbedingungen:
Please refer to datasheet
Hersteller:
Rockland Inc
Reaktivitäten:
Mouse
Immunogen:
Expression system for standard: NSO; Immunogen sequence: E22-V352
Spezies:
Mouse
Uniprot:
Q9QWK4
Synonyme:
1/6;A;AAC-;AAC-11;AI047839;AIM;AIM/Spalpha;Api6;apoptosis inhibitor 6;apoptosis inhibitor expressed by macrophages;Apoptosis inhibitory 6;CD5 antigen-like;CT-2;CT2;mAIM;Pdp;Pdp 1/6;Sp;Sp-alpha
Weitere Details:
CD5 antigen-like, also known as Sp alpha and AIM, is a protein that in humans is encoded by the CD5L gene. It is mapped to 1q21-q23 by fluorescence in situ hybridization. It is found that Aim expression is induced in mouse macrophages in response to loading with highly oxidized low density lipoprotein (oxLDL), and that Aim is expressed in foam cells within atherosclerotic lesions. Both the expression of Aim in lesions and its induction by oxLDL require Lxr /Rxr heterodimers. Aim-null macrophages are highly susceptible to oxLDL-induced apoptosis in vitro and undergo accelerated apoptosis in atherosclerotic lesions in vivo. Double knockout of Aim and Ldlr reduce atherosclerotic lesions. Therefore, it is concluded that AIM expression protects macrophages from apoptosis within atherosclerotic lesions, promoting early lesion development.
Versandbedingungen:
Blue Ice